|
1
|
Bowtell DD: The genesis and evolution of
high-grade serous ovarian cancer. Nat Rev Cancer. 10:803–808. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Siegel RL, Miller KD, Fedewa SA, Ahnen DJ,
Meester RGS, Barzi A and Jemal A: Colorectal cancer statistics,
2017. CA Cancer J Clin. 67:177–193. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ledermann JA, Embleton AC, Raja F, Perren
TJ, Jayson GC, Rustin GJS, Kaye SB, Hirte H, Eisenhauer E, Vaughan
M, et al: Cediranib in patients with relapsed platinum-sensitive
ovarian cancer (ICON6): A randomised, double-blind,
placebo-controlled phase 3 trial. Lancet. 387:1066–1074. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Shevade A, Strogolova V, Orlova M, Yeo CT
and Kuchin S: Mitochondrial voltage-dependent anion channel protein
Por1 positively regulates the nuclear localization of saccharomyces
cerevisiae AMP-activated protein kinase. mSphere. 3(pii):
e00482–17. 2018.PubMed/NCBI
|
|
5
|
Zhang X, Lv H, Zhou Q, Elkholi R, Chipuk
JE, Reddy MV, Reddy EP and Gallo JM: Preclinical pharmacological
evaluation of a novel multiple kinase inhibitor, ON123300, in brain
tumor models. Mol Cancer Ther. 13:1105–1116. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Cao D, Li D, Huang Y, Ma Y, Zhang B, Zhao
C, Deng S, Luo M, Yin T, Wei YQ and Wang W: 5-azacytidine promotes
invadopodia formation and tumor metastasis through the upregulation
of PI3K in ovarian cancer cells. Oncotarget. 8:60173–60187.
2017.PubMed/NCBI
|
|
7
|
Nehate C, Moothedathu Raynold AA and Koul
V: ATRP fabricated and short chain polyethylenimine grafted redox
sensitive polymeric nanoparticles for codelivery of anticancer drug
and siRNA in cancer therapy. ACS Appl Mater Interfaces.
9:39672–39687. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Stubelius A, Andersson A, Islander U and
Carlsten H: Ovarian hormones in innate inflammation. Immunobiology.
222:878–883. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Li L, Gong M, Zhao Y, Zhao X and Li Q:
FOXK1 facilitates cell proliferation through regulating the
expression of p21, and promotes metastasis in ovarian cancer.
Oncotarget. 8:70441–70451. 2017.PubMed/NCBI
|
|
10
|
Peng F, Zhong Y, Liu Y, Zhang Y, Xie Y, Lu
Y, Zhang X and Li D: SPARC suppresses lymph node metastasis by
regulating the expression of VEGFs in ovarian carcinoma. Int J
Oncol. 51:1920–1928. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Mu QJ, Li HL, Yao Y, Liu SC, Yin CG and Ma
XZ: Chromodomain helicase/ATPase DNA-binding protein 1-like gene
(CHD1L) expression and implications for invasion and metastasis of
breast cancer. PLoS One. 10:e01430302015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Suzuki A, Lu J, Kusakai G, Kishimoto A,
Ogura T and Esumi H: ARK5 is a tumor invasion-associated factor
downstream of Akt signaling. Mol Cell Biol. 24:3526–3535. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Shi L, Sun X, Zhang J, Zhao C, Li H, Liu
Z, Fang C, Wang X, Zhao C, Zhang X, et al: Gab2 expression in
glioma and its implications for tumor invasion. Acta Oncol.
52:1739–1750. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Tang J, Qin Z, Han P, Wang W, Yang C, Xu
Z, Li R, Liu B, Qin C, Wang Z, et al: High Annexin A5 expression
promotes tumor progression and poor prognosis in renal cell
carcinoma. Int J Oncol. 50:1839–1847. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wang Y and Zhou BP: Epithelial-mesenchymal
transition in breast cancer progression and metastasis. Chin J
Cancer. 30:603–611. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Xu T, Zhang J, Chen W, Pan S, Zhi X, Wen
L, Zhou Y, Chen BW, Qiu J, Zhang Y, et al: ARK5 promotes
doxorubicin resistance in hepatocellular carcinoma via
epithelial-mesenchymal transition. Cancer Lett. 377:140–148. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Lue H, Thiele M, Franz J, Dahl E,
Speckgens S, Leng L, Fingerle-Rowson G, Bucala R, Lüscher B and
Bernhagen J: Macrophage migration inhibitory factor (MIF) promotes
cell survival by activation of the Akt pathway and role for
CSN5/JAB1 in the control of autocrine MIF activity. Oncogene.
26:5046–5059. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Lamouille S, Connolly E, Smyth JW, Akhurst
RJ and Derynck R: TGF-β-induced activation of mTOR complex 2 drives
epithelial-mesenchymal transition and cell invasion. J Cell Sci.
125:1259–1273. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Li M, Zheng C, Xu H, He W, Ruan Y, Ma J,
Zheng J, Ye C and Li W: Inhibition of AMPK-related kinase 5 (ARK5)
enhances cisplatin cytotoxicity in non-small cell lung cancer cells
through regulation of epithelial-mesenchymal transition. Am J
Transl Res. 9:1708–1719. 2017.PubMed/NCBI
|
|
20
|
Kusakai G, Suzuki A, Ogura T, Kaminishi M
and Esumi H: Strong association of ARK5 with tumor invasion and
metastasis. J Exp Clin Cancer Res. 23:263–268. 2004.PubMed/NCBI
|
|
21
|
Lu S, Niu N, Guo H, Tang J, Guo W, Liu Z,
Shi L, Sun T, Zhou F, Li H, et al: ARK5 promotes glioma cell
invasion, and its elevated expression is correlated with poor
clinical outcome. Eur J Cancer. 49:752–763. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zhang HY, Li JH, Li G and Wang SR:
Activation of ARK5/miR-1181/HOXA10 axis promotes
epithelial-mesenchymal transition in ovarian cancer. Oncol Rep.
34:1193–1202. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Phippen NT, Bateman NW, Wang G, Conrads
KA, Ao W, Teng PN, Litzi TA, Oliver J, Maxwell GL, Hamilton CA, et
al: NUAK1 (ARK5) is associated with poor prognosis in ovarian
cancer. Front Oncol. 6:2132016. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Roh SA, Choi EY, Cho DH, Jang SJ, Kim SY,
Kim YS and Kim JC: Growth and invasion of sporadic colorectal
adenocarcinomas in terms of genetic change. J Korean Med Sci.
25:353–360. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Long H, Xie R, Xiang T, Zhao Z, Lin S,
Liang Z, Chen Z and Zhu B: Autocrine CCL5 signaling promotes
invasion and migration of CD133+ ovarian cancer stem-like cells via
NF-κB-mediated MMP-9 upregulation. Stem Cells. 30:2309–2319. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Liao TT and Yang MH: Revisiting
epithelial-mesenchymal transition in cancer metastasis: The
connection between epithelial plasticity and stemness. Mol Oncol.
11:792–804. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Shi L, Zhang B, Sun X, Lu S, Liu Z, Liu Y,
Li H, Wang L, Wang X and Zhao C: MiR-204 inhibits human NSCLC
metastasis through suppression of NUAK1. Br J Cancer.
111:2316–2327. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Suzuki A, Kusakai G, Kishimoto A, Lu J,
Ogura T, Lavin MF and Esumi H: Identification of a novel protein
kinase mediating Akt survival signaling to the ATM protein. J Biol
Chem. 278:48–53. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Yu J, Tao S, Hu P, Wang R, Fang C, Xu Y,
Qi D, Wei Z, Zhang J and Tan Q: CCR7 promote lymph node metastasis
via regulating VEGF-C/D-R3 pathway in lung adenocarcinoma. J
Cancer. 8:2060–2068. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Martin TA and Jiang WG: Anti-cancer agents
in medicinal chemistry (formerly current medicinal
chemistry-anti-cancer agents). Anticancer Agents Med Chem.
10:12010. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Cheng K and Hao M: Metformin inhibits
TGF-β1-induced epithelial-to-mesenchymal transition via PKM2
relative-mTOR/p70s6k signaling pathway in cervical carcinoma cells.
Int J Mol Sci. 17(pii): E20002016. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Suzuki A, Kusakai G, Kishimoto A, Shimojo
Y, Miyamoto S, Ogura T, Ochiai A and Esumi H: Regulation of
caspase-6 and FLIP by the AMPK family member ARK5. Oncogene.
23:7067–7075. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Brunet A, Bonni A, Zigmond MJ, Lin MZ, Juo
P, Hu LS, Anderson MJ, Arden KC, Blenis J and Greenberg ME: Akt
promotes cell survival by phosphorylating and inhibiting a Forkhead
transcription factor. Cell. 96:857–868. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Chen D, Liu G, Xu N, You X, Zhou H, Zhao X
and Liu Q: Knockdown of ARK5 expression suppresses invasion and
metastasis of gastric cancer. Cell Physiol Biochem. 42:1025–1036.
2017. View Article : Google Scholar : PubMed/NCBI
|
